Microbot Medical Inc.
MBOT
NASDAQ·Healthcare·Medical - Devices·Mkt cap $65.6M
$1.44
▲ 0.00%
P/E
-5.63
Mkt Cap
$65.6M
52-Wk Range
$1.44–$4.67
52-Week Range
$1.44 - $4.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 68.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary micro-robotic technology with extensive patent protection (42 issued, 23 pending patents)
- Strategic partnership with Stryker Corporation for co-development and commercialization
- First-mover advantage in robotic endoluminal surgery devices
- Diversified product pipeline targeting multiple high-value surgical procedures
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Increasing adoption of minimally invasive surgical procedures globally
Value
Deep value opportunity - significant discount to sector peers
Momentum
Falling
-21.7% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying MBOT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 6, 2026
AUG 11, 2026
Reported EPS of -$0.08 vs -$0.08 consensus (-4.3% surprise). Revenue of $241.0K vs $200.0K expected (+20.5%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-4.3%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$105.0K
$241.0K
Margins · last 8Q
Profit
232.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Loop Capital · $4.00 · Jun 3, 2026
vs Industry
How MBOT stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.